Polyoxometalate Catalyst Renders Nerve Agents Harmless
|
By HospiMedica International staff writers Posted on 30 Apr 2019 |

Image: Dr. Anatoly Frenkel next to the XPS powder diffraction beamline (Photo courtesy of BNL).
A new study describes a polyoxometalate (POM) catalyst that decomposes nerve agents, eliminating their harmful and lethal effects.
Researchers at Brookhaven National Laboratory (BNL; Upton, NY, USA) and Stony Brook University (SBU; NY, USA) conducted a study to investigate the decomposition process of the nerve agent Sarin and its simulant, dimethyl chlorophosphate (DMCP), using a zirconium polytungstate POM. To do so, they used x-ray photoelectron spectroscopy (XPS), a research technique that uses ultrabright x-rays to measure the elemental composition of a sample. They thus observed a change in the charge state of the zirconium atom in the POM molecule.
By comparing diffraction patterns, they found that the disordering of the zirconium-POM crystal lattice resulted in adsorption of the Sarin simulant molecules. Using computer models, they then showed that the resulting structural changes of the POM catalyst exposed zirconium atoms to Sarin, and that these interactions were responsible for the decomposition of DMCP by a tungstate monomerization process that activated nucleophilic hydrolysis. The study was published on April 19, 2019, in the Journal of Physical Chemistry Letters.
“Usually, a catalyst is a rigid structure that remains stable. Initially, this catalyst was a dimer, two big molecules connected by two bridging bonds. It looked like a bicycle with two wheels and a frame connecting them,” said lead author Anatoly Frenkel, PhD, of BNL and SBU. “What we understood after looking at the catalyst is that the bicycle broke into two 'wheels' and the 'frame' was cut. The process of breaking the dimer was equivalent to activating the catalyst.”
“Our work is part of an ongoing, multiagency effort to protect soldiers and civilians from chemical warfare agents,” concluded Dr. Frenkel. “The research requires us to understand molecular interactions on a very small scale, and to develop special characterization methods that are capable of observing those interactions. It is a very complex set of problems that also has a very immediate societal impact.”
Sarin is an extremely toxic synthetic organophosphorus compound generally considered as a weapon of mass destruction. A colorless, odorless liquid, it is an extremely potency nerve agent, with exposure lethal even at very low concentrations, and death occurring within ten minutes of direct inhalation of a lethal dose due to suffocation from lung muscle paralysis. People who absorb a non-lethal dose, but do not receive immediate medical treatment, may suffer permanent neurological damage.
Related Links:
Brookhaven National Laboratory
Stony Brook University
Researchers at Brookhaven National Laboratory (BNL; Upton, NY, USA) and Stony Brook University (SBU; NY, USA) conducted a study to investigate the decomposition process of the nerve agent Sarin and its simulant, dimethyl chlorophosphate (DMCP), using a zirconium polytungstate POM. To do so, they used x-ray photoelectron spectroscopy (XPS), a research technique that uses ultrabright x-rays to measure the elemental composition of a sample. They thus observed a change in the charge state of the zirconium atom in the POM molecule.
By comparing diffraction patterns, they found that the disordering of the zirconium-POM crystal lattice resulted in adsorption of the Sarin simulant molecules. Using computer models, they then showed that the resulting structural changes of the POM catalyst exposed zirconium atoms to Sarin, and that these interactions were responsible for the decomposition of DMCP by a tungstate monomerization process that activated nucleophilic hydrolysis. The study was published on April 19, 2019, in the Journal of Physical Chemistry Letters.
“Usually, a catalyst is a rigid structure that remains stable. Initially, this catalyst was a dimer, two big molecules connected by two bridging bonds. It looked like a bicycle with two wheels and a frame connecting them,” said lead author Anatoly Frenkel, PhD, of BNL and SBU. “What we understood after looking at the catalyst is that the bicycle broke into two 'wheels' and the 'frame' was cut. The process of breaking the dimer was equivalent to activating the catalyst.”
“Our work is part of an ongoing, multiagency effort to protect soldiers and civilians from chemical warfare agents,” concluded Dr. Frenkel. “The research requires us to understand molecular interactions on a very small scale, and to develop special characterization methods that are capable of observing those interactions. It is a very complex set of problems that also has a very immediate societal impact.”
Sarin is an extremely toxic synthetic organophosphorus compound generally considered as a weapon of mass destruction. A colorless, odorless liquid, it is an extremely potency nerve agent, with exposure lethal even at very low concentrations, and death occurring within ten minutes of direct inhalation of a lethal dose due to suffocation from lung muscle paralysis. People who absorb a non-lethal dose, but do not receive immediate medical treatment, may suffer permanent neurological damage.
Related Links:
Brookhaven National Laboratory
Stony Brook University
Latest Critical Care News
- 'Universal' Kidney to Match Any Blood Type
- AI Heart Attack Risk Assessment Tool Outperforms Existing Methods
- Smartphone Imaging System Enables Early Oral Cancer Detection
- Swallowable Pill-Sized Bioprinter Treats GI Tract Injuries

- Personalized Brain “Pacemakers” Could Help Patients with Hard-To-Treat Epilepsy
- Microscopic DNA Flower Robots to Enable Precision Medicine Delivery
- Origami Robots to Deliver Medicine Less Invasively and More Effectively
- Improved Cough-Detection Technology Aids Health Monitoring
- AI Identifies Children in ER Likely to Develop Sepsis Within 48 Hours
- New Radiofrequency Therapy Slows Glioblastoma Growth
- Battery-Free Wireless Multi-Sensing Platform Revolutionizes Pressure Injury Detection
- Multimodal AI to Revolutionize Cardiovascular Disease Diagnosis and Treatment
- AI System Reveals Hidden Diagnostic Patterns in Electronic Health Records
- Highly Sensitive On-Skin Sensing Monitor Detects Vitamin B6 and Glucose in Sweat
- Artificial Intelligence Revolutionizing Pediatric Anesthesia Management
- New Device Detects Tuberculosis DNA Directly in Exhaled Air
Channels
Surgical Techniques
view channel
Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
Intracerebral hemorrhage, a type of stroke caused by bleeding deep within the brain, remains one of the most challenging neurological emergencies to treat. Accounting for about 15% of all strokes, it carries... Read more
Novel Glue Prevents Complications After Breast Cancer Surgery
Seroma and prolonged lymphorrhea are among the most common complications following axillary lymphadenectomy in breast cancer patients. These postoperative issues can delay recovery and postpone the start... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







